We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$4.31M
Cap. Flow %
-1.81%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19

Top Buys

Rank Stock Value
1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

Rank Sector Weight
1 Healthcare 32.49%
2 Materials 25.45%
3 Financials 10.86%
4 Real Estate 6.17%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEM icon
101
Newmont
NEM
$98.5B
$84K 0.04%
2,000
– –
OXY icon
102
Occidental Petroleum
OXY
$54.6B
$78K 0.03%
1,273
-158
-11% -$10.1K
MDGL icon
103
Madrigal Pharmaceuticals
MDGL
$12.7B
$65K 0.03%
+1,000
New +$69.5K
TGNA
104
DELISTED
TEGNA Inc
TGNA
$62K 0.03%
3,000
– –
OGN icon
105
Organon & Co
OGN
$3.56B
$57K 0.02%
2,450
– –
IWP icon
106
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$55K 0.02%
695
– –
DHR icon
107
Danaher
DHR
$138B
$46K 0.02%
203
– –
AMZN icon
108
Amazon
AMZN
$2.49T
$34K 0.01%
300
– –
IEFA icon
109
iShares Core MSCI EAFE ETF
IEFA
$188B
$33K 0.01%
633
– –
AVGO icon
110
Broadcom
AVGO
$1.82T
$32K 0.01%
710
– –
GOOGL icon
111
Alphabet (Google) Class A
GOOGL
$3.99T
$29K 0.01%
300
– –
UNH icon
112
UnitedHealth
UNH
$379B
$29K 0.01%
57
– –
IJR icon
113
iShares Core S&P Small-Cap ETF
IJR
$110B
$27K 0.01%
313
-197
-39% -$19.1K
IWS icon
114
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$26K 0.01%
273
– –
CVS icon
115
CVS Health
CVS
$137B
$25K 0.01%
258
– –
BDX icon
116
Becton Dickinson
BDX
$43.8B
$24K 0.01%
+106
New +$26.4K
EXP icon
117
Eagle Materials
EXP
$6.69B
$24K 0.01%
228
– –
IWO icon
118
iShares Russell 2000 Growth ETF
IWO
$14.4B
$24K 0.01%
118
– –
MS icon
119
Morgan Stanley
MS
$337B
$23K 0.01%
293
– –
TMO icon
120
Thermo Fisher Scientific
TMO
$208B
$23K 0.01%
45
– –
CB icon
121
Chubb
CB
$139B
$22K 0.01%
121
– –
HD icon
122
Home Depot
HD
$335B
$22K 0.01%
80
– –
IQV icon
123
IQVIA
IQV
$35.6B
$22K 0.01%
122
– –
PWR icon
124
Quanta Services
PWR
$93.1B
$22K 0.01%
+176
New +$24.1K
EQIX icon
125
Equinix
EQIX
$103B
$21K 0.01%
37
– –
3 4
5
6 7

Similar funds

DI
Disciplined Investors Waco, Texas $168M AUM 23.6% 1-Year Est. Return
WFS
Widmann Financial Services Bowie, Maryland $168M AUM 24.36% 1-Year Est. Return
CCG
Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return
7CM
7G Capital Management New York $168M AUM 45.68% 1-Year Est. Return
MAG
Meadowbrook Advisors Group Bedminster, New Jersey $168M AUM
PFA
Presper Financial Architects Akron, Ohio $168M AUM 12.94% 1-Year Est. Return
CW
Code Waechter Tampa, Florida $168M AUM 15.56% 1-Year Est. Return
IWA
Integrity Wealth Advisors Ventura, California $168M AUM 18.33% 1-Year Est. Return

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Materials and Financials.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.